<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sequencing of the <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> genome revealed <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in isocitrate dehydrogenase-1 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0004808'>Acute myeloid leukemia</z:hpo> frequently develops from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In order to test whether <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> also carries isocitrate dehydrogenase-1 mutations, we stained a series of bone marrow samples from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> using an antibody specific for the R132H mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Three out of 71 patients exhibited antibody binding to myeloid precursor cells </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of the R132H mutation was confirmed by DNA sequencing </plain></SENT>
<SENT sid="5" pm="."><plain>We demonstrated that isocitrate dehydrogenase-1 mutations occur in <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> preceding <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and that the R132H alteration can be detected by immunohistochemistry </plain></SENT>
</text></document>